Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology - Top-Institutions - MDSpire

Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology

  • By

  • Xiaoxuan Xing

  • Ke Wang

  • Yingnan Feng

  • Chao Wu

  • Lihua Jia

  • Huiying Li

  • Zhiyong Wen

  • Yinan Tang

  • Zhizhou Wang

  • Xiaotong Zhang

  • Xiaoxi Li

  • Yiming Hua

  • Lan Zhang

  • Xianzhe Dong

  • June 22, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, Missouri

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #2

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Neurology
    • Memory and Aging

Original Source(s)

Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology

  • by Xiaoxuan Xing, Ke Wang, Yingnan Feng, Chao Wu, Lihua Jia, Huiying Li, Zhiyong Wen, Yinan Tang, Zhizhou Wang, Xiaotong Zhang, Xiaoxi Li, Yiming Hua, Lan Zhang, Xianzhe Dong

  • June 22, 2026

Related Content

Editorial: Association of diabetes mellitus with cognitive impairment and neurological disorders, volume II

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease